"Well begun is half done" – Aristotle
Clearly, Aristotle never worked to bring an innovative medical device to market.
The sooner you start thinking about how your product will delight clinical AND non-clinical customers, the more likely you are to optimize the market access and patient access that is critical to your success.
Beyond the challenges associated with gaining regulatory approval, there are hurdles to overcome as you enter the real world with your innovation. Many of these challenges can be addressed through understanding the non-clinical and clinical situation, building integrated plans for evidence to quantify and communicate the value of your solution, and market access & reimbursement strategies to ensure access and adoption.
On November 15, Brian, Diane and Trisha will discuss today's market access landscape for medical devices and how to ensure you are starting early with a plan to succeed. Don't miss the opportunity to apply for a one-on-one meeting with these experts as a forum to further discuss your company and personal reimbursement path.
11:00am | Registration Opens
11:30am | Presentations
12:15pm | Q&A
12:30pm | Lunch & Networking
1:30pm | Program Close
1:30-5:00pm | One-on-one Meetings*
*Companies must have applied for a one-on-one meeting ahead of time and been approved. In your application, be sure to describe potential market access (reimbursement, pricing, etc.) barriers or opportunities you have identified. The application period has ended.
Brian Vaughn | Leader - Global Health Economics & Market Access, Ethicon read bio»
Diane Francis | Senior Director, US Health Economics and Market Access, Ethicon read bio»
Trisha Hutzul | Senior Director, Global Health Economics and Market Access, Johnson & Johnson MD&D read bio»
Presentation & Lunch
CA$ 40 | General Public
CA$ 30 | Student/Academic
CA$ 55 | At the door
Includes presentation, Q&A, and lunch. All attendees must pay this fee, regardless of one-on-one meeting status. Registration to attend the presentation, Q&A, and lunch will remain open until noon on November 14th, 2016 (or sold out).
FREE | Application
FREE | Accepted Companies
Companies must have applied for a one-on-one meeting ahead of time. In your application, be sure to describe potential market access (reimbursment, pricing, etc.) barriers or opportunities you have identified. The one-on-one application has ended. Your application will be reviewed and you will be notified of acceptance by email on November 10th, 2016. Acceptance of a one-on-one meeting is not guaranteed as all applications must be approved.
JLABS @ Toronto
661 University Ave, Suite 1300
Brian Vaughn | Leader - Global Health Economics & Market Access, Ethicon, Inc.
Brian has worked in the business of healthcare for over 25 years and is currently the Leader of Global Health Economics and Market Access at ETHICON Inc.. Brian and his Team are responsible for developing and executing integrated market access, health economic and outcomes research strategies across all stages of the product life cycle. Brian is passionate about innovation and enjoys helping to quantify, communicate and capture the value of innovative technologies to ensure that they are accessible to the patients that will benefit most from their successful launch and adoption. His responsibilities include helping to shape the innovation strategy, market access assessment, strategy & execution, optimization of non-clinical value propositions, life cycle evidence of value strategies and informing strategic pricing. Since joining Johnson and Johnson in 1999 Brian has worked extensively in the US and globally. His experience spans the range of HEMA strategy and tactics with focus on health economics, outcomes research, reimbursement and market access. He has worked in numerous surgical specialties including minimally invasive cardiac surgery, aesthetic & reconstructive plastic surgery, women's health, orthopedics & sports medicine, metabolics & bariatrics and general surgery. His areas of product/technology focus have included wound management, wound closure, advanced energy and endo-mechanical surgical devices. Prior to Joining Johnson & Johnson Brian worked in Managed Care in the Metro New York Market. Brian held a number of leadership roles in Medical Delivery Systems building and managing delivery networks and leading Teams responsible for hospital and health systems contracting. Brian has an MPA in Healthcare Policy and Management and an MBA in Marketing. Throughout his career Brian has shown passion for leadership, working with Teams and helping the people around him to achieve their personal and professional goals.
Connect with Brian:
Diane M. Francis, MPH | Senior Director, US Health Economics and Market Access, Ethicon US, LLC
Diane Francis has more than 25 years of diverse experience in community development, hospital administration and medical device market access. Prior to joining Johnson & Johnson, Diane led a variety of community health and managed care initiatives. She founded a non-profit organization that focuses on economic literacy and empowerment. She also established and then served as CEO of a NJ physician-hospital organization (PHO) providing managed care contracting and revenue cycle management services. In 2000, Diane joined Johnson & Johnson, where she has specialized in health economic, reimbursement, and evidence strategies for medical devices, from product concept through commercialization. She has served in supported a variety of businesses and held positions of increase responsibility. Currently, Diane is Senior Director of Health Economic and Market Access at ETHICON for the U.S. There she leads a team that delivers innovative health economic solutions that enhance product and business competitiveness in the evolving value-based health care system. Recently, one of her innovative economic solutions was recognized by an innovation award. She holds a Bachelors of Arts from Cornell University and Masters of Public Health from Columbia University.
Connect with Diane:
Trisha Hutzul | Senior Director Global Health Economics and Market Access, Johnson & Johnson MD&D
Trisha Hutzul currently functions as the Global Transformation Lead for the Johnson and Johnson Health Economics and Market Access Center of Excellence. In this role she is responsible for working across the Research and Development (R&D) organization to identify synergies and interdependencies with partners from R&D, clinical, medical, regulatory and supply chain. Prior to this recent posting, Trisha worked as the Senior Director of Surgical Innovation (HEMA) for the medical device division of Ethicon. In this role she was responsible for leading a team dedicated to the creation of strategic market access plans and evidence of value. Her scope included front end strategy development and support of external early innovation. Trisha is a Graduate of the University of Toronto and the Johns Hopkins School of Public Health, Medical Institutes. She entered the pharmaceutical industry 15 years ago as an Intern Scientist and has held positions of increasing responsibility across both the pharmaceutical and device sectors ever since. Her work has spanned market access, professional medical education and health care policy. Prior to joining the Johnson and Johnson Global team in 2013, Trisha held the position of Medical Affairs Director Johnson and Johnson Medical Companies Canada. In this position she was responsible for the development of the local research and medical education plans. Trisha has held positions that have supported research in both the developed and developing markets, and past work has included the development of emerging markets access plans to support early adoption and lifecycle management in BRIC (Brazil , Russia, India and China. Trisha has a passion for innovation, and is currently enrolled in the Kellogg Executive Scholars Program Northwestern University. She is also and mentor and sponsor of cross sector talent development.
Connect with Trisha:
When & Where
JLABS @ Toronto
JLABS, part of Johnson & Johnson Innovation, is a network of life science incubators providing emerging companies many of the advantages of being in a big company, without the capital investment. JLABS offers singular bench tops, modular wet lab units and office space on a short-term basis, allowing companies to pay only for the space they need, with an option to quickly expand when they have the resources to do so. Companies residing at JLABS also have access to core research labs hosting specialized capital equipment and shared administrative areas. JLABS is an open innovation model, and the agreement for space does not grant JLABS or Johnson & Johnson Innovation any stake or rights in the companies, nor will the companies have a guaranteed future affiliation with JLABS. The flagship facility is located in San Diego at Janssen's West Coast Research Center, and JLABS has now two established locations in San Francisco - one through a collaboration with the California Institute for Quantitative Biosciences (QB3) and a second standalone facility - one in Boston through a collaboration with Lab Central, one in Houston through a collaboration with TMC, and one in Toronto through a collaboration with MaRS. For more information please visit jlabs.jnjinnovation.com.